nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.172	0.248	CbGbCtD
Desvenlafaxine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.131	0.188	CbGbCtD
Desvenlafaxine—CYP3A4—Betamethasone—ankylosing spondylitis	0.112	0.161	CbGbCtD
Desvenlafaxine—CYP3A4—Prednisolone—ankylosing spondylitis	0.111	0.159	CbGbCtD
Desvenlafaxine—CYP3A4—Prednisone—ankylosing spondylitis	0.104	0.15	CbGbCtD
Desvenlafaxine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0652	0.0938	CbGbCtD
Desvenlafaxine—Suicidal ideation—Betamethasone—ankylosing spondylitis	0.00401	0.0132	CcSEcCtD
Desvenlafaxine—Mania—Betamethasone—ankylosing spondylitis	0.00387	0.0127	CcSEcCtD
Desvenlafaxine—Mania—Dexamethasone—ankylosing spondylitis	0.00387	0.0127	CcSEcCtD
Desvenlafaxine—Blood triglycerides increased—Prednisone—ankylosing spondylitis	0.00374	0.0123	CcSEcCtD
Desvenlafaxine—Suicidal ideation—Prednisone—ankylosing spondylitis	0.0035	0.0115	CcSEcCtD
Desvenlafaxine—Mania—Prednisone—ankylosing spondylitis	0.00337	0.0111	CcSEcCtD
Desvenlafaxine—Interstitial lung disease—Methotrexate—ankylosing spondylitis	0.0029	0.0095	CcSEcCtD
Desvenlafaxine—Proteinuria—Methotrexate—ankylosing spondylitis	0.00233	0.00765	CcSEcCtD
Desvenlafaxine—Protein urine present—Methotrexate—ankylosing spondylitis	0.0023	0.00755	CcSEcCtD
Desvenlafaxine—Musculoskeletal stiffness—Methotrexate—ankylosing spondylitis	0.00228	0.00749	CcSEcCtD
Desvenlafaxine—Bone disorder—Methotrexate—ankylosing spondylitis	0.00227	0.00744	CcSEcCtD
Desvenlafaxine—Irritability—Methylprednisolone—ankylosing spondylitis	0.00215	0.00704	CcSEcCtD
Desvenlafaxine—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00203	0.00666	CcSEcCtD
Desvenlafaxine—Irritability—Dexamethasone—ankylosing spondylitis	0.00195	0.0064	CcSEcCtD
Desvenlafaxine—Irritability—Betamethasone—ankylosing spondylitis	0.00195	0.0064	CcSEcCtD
Desvenlafaxine—Weight increased—Prednisolone—ankylosing spondylitis	0.00193	0.00632	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.00186	0.0061	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.00185	0.00607	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Prednisone—ankylosing spondylitis	0.00178	0.00584	CcSEcCtD
Desvenlafaxine—Weight increased—Triamcinolone—ankylosing spondylitis	0.00177	0.00581	CcSEcCtD
Desvenlafaxine—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00177	0.0058	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.00171	0.00561	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.00171	0.0056	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.0017	0.00558	CcSEcCtD
Desvenlafaxine—Irritability—Prednisone—ankylosing spondylitis	0.0017	0.00557	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.0017	0.00557	CcSEcCtD
Desvenlafaxine—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00164	0.00537	CcSEcCtD
Desvenlafaxine—Weight increased—Betamethasone—ankylosing spondylitis	0.00161	0.00527	CcSEcCtD
Desvenlafaxine—Weight increased—Dexamethasone—ankylosing spondylitis	0.00161	0.00527	CcSEcCtD
Desvenlafaxine—Weight decreased—Dexamethasone—ankylosing spondylitis	0.0016	0.00524	CcSEcCtD
Desvenlafaxine—Weight decreased—Betamethasone—ankylosing spondylitis	0.0016	0.00524	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.00155	0.00509	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.00155	0.00509	CcSEcCtD
Desvenlafaxine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00155	0.00508	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.00154	0.00506	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.00154	0.00506	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00153	0.00501	CcSEcCtD
Desvenlafaxine—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00145	0.00477	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00144	0.00473	CcSEcCtD
Desvenlafaxine—Irritability—Methotrexate—ankylosing spondylitis	0.00142	0.00466	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00142	0.00465	CcSEcCtD
Desvenlafaxine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00141	0.00463	CcSEcCtD
Desvenlafaxine—Hallucination—Betamethasone—ankylosing spondylitis	0.00141	0.00462	CcSEcCtD
Desvenlafaxine—Hallucination—Dexamethasone—ankylosing spondylitis	0.00141	0.00462	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.0014	0.00461	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.0014	0.0046	CcSEcCtD
Desvenlafaxine—Weight increased—Prednisone—ankylosing spondylitis	0.0014	0.00459	CcSEcCtD
Desvenlafaxine—Weight decreased—Prednisone—ankylosing spondylitis	0.00139	0.00457	CcSEcCtD
Desvenlafaxine—Vision blurred—Prednisolone—ankylosing spondylitis	0.00139	0.00456	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00137	0.00451	CcSEcCtD
Desvenlafaxine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00136	0.00447	CcSEcCtD
Desvenlafaxine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00135	0.00444	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00135	0.00444	CcSEcCtD
Desvenlafaxine—Angioedema—Prednisolone—ankylosing spondylitis	0.00135	0.00442	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00134	0.00441	CcSEcCtD
Desvenlafaxine—Breast disorder—Methotrexate—ankylosing spondylitis	0.00134	0.00441	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00134	0.00439	CcSEcCtD
Desvenlafaxine—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00133	0.00436	CcSEcCtD
Desvenlafaxine—Vertigo—Prednisolone—ankylosing spondylitis	0.00133	0.00435	CcSEcCtD
Desvenlafaxine—Syncope—Prednisolone—ankylosing spondylitis	0.00132	0.00434	CcSEcCtD
Desvenlafaxine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00132	0.00433	CcSEcCtD
Desvenlafaxine—Eye disorder—Betamethasone—ankylosing spondylitis	0.00132	0.00433	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.0013	0.00425	CcSEcCtD
Desvenlafaxine—Angiopathy—Betamethasone—ankylosing spondylitis	0.00128	0.00421	CcSEcCtD
Desvenlafaxine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00128	0.00421	CcSEcCtD
Desvenlafaxine—Convulsion—Prednisolone—ankylosing spondylitis	0.00128	0.00419	CcSEcCtD
Desvenlafaxine—Hypertension—Prednisolone—ankylosing spondylitis	0.00127	0.00418	CcSEcCtD
Desvenlafaxine—Alopecia—Betamethasone—ankylosing spondylitis	0.00125	0.0041	CcSEcCtD
Desvenlafaxine—Alopecia—Dexamethasone—ankylosing spondylitis	0.00125	0.0041	CcSEcCtD
Desvenlafaxine—Angioedema—Triamcinolone—ankylosing spondylitis	0.00124	0.00407	CcSEcCtD
Desvenlafaxine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00124	0.00406	CcSEcCtD
Desvenlafaxine—Hallucination—Prednisone—ankylosing spondylitis	0.00123	0.00402	CcSEcCtD
Desvenlafaxine—Vertigo—Triamcinolone—ankylosing spondylitis	0.00122	0.004	CcSEcCtD
Desvenlafaxine—Syncope—Triamcinolone—ankylosing spondylitis	0.00122	0.00399	CcSEcCtD
Desvenlafaxine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00122	0.00399	CcSEcCtD
Desvenlafaxine—Syncope—Methylprednisolone—ankylosing spondylitis	0.00121	0.00398	CcSEcCtD
Desvenlafaxine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00121	0.00397	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00119	0.00391	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00119	0.0039	CcSEcCtD
Desvenlafaxine—Shock—Prednisolone—ankylosing spondylitis	0.00118	0.00389	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00118	0.00388	CcSEcCtD
Desvenlafaxine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00118	0.00386	CcSEcCtD
Desvenlafaxine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00117	0.00385	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00117	0.00385	CcSEcCtD
Desvenlafaxine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00117	0.00385	CcSEcCtD
Desvenlafaxine—Hypertension—Triamcinolone—ankylosing spondylitis	0.00117	0.00384	CcSEcCtD
Desvenlafaxine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00117	0.00383	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00116	0.00382	CcSEcCtD
Desvenlafaxine—Eye disorder—Prednisone—ankylosing spondylitis	0.00115	0.00377	CcSEcCtD
Desvenlafaxine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00115	0.00377	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00114	0.00375	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00114	0.00373	CcSEcCtD
Desvenlafaxine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00113	0.00371	CcSEcCtD
Desvenlafaxine—Angioedema—Dexamethasone—ankylosing spondylitis	0.00112	0.00369	CcSEcCtD
Desvenlafaxine—Angioedema—Betamethasone—ankylosing spondylitis	0.00112	0.00369	CcSEcCtD
Desvenlafaxine—Angiopathy—Prednisone—ankylosing spondylitis	0.00112	0.00366	CcSEcCtD
Desvenlafaxine—Immune system disorder—Prednisone—ankylosing spondylitis	0.00111	0.00365	CcSEcCtD
Desvenlafaxine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00111	0.00363	CcSEcCtD
Desvenlafaxine—Vertigo—Betamethasone—ankylosing spondylitis	0.00111	0.00363	CcSEcCtD
Desvenlafaxine—Syncope—Betamethasone—ankylosing spondylitis	0.0011	0.00362	CcSEcCtD
Desvenlafaxine—Syncope—Dexamethasone—ankylosing spondylitis	0.0011	0.00362	CcSEcCtD
Desvenlafaxine—Shock—Triamcinolone—ankylosing spondylitis	0.00109	0.00357	CcSEcCtD
Desvenlafaxine—Insomnia—Prednisolone—ankylosing spondylitis	0.00109	0.00357	CcSEcCtD
Desvenlafaxine—Alopecia—Prednisone—ankylosing spondylitis	0.00109	0.00357	CcSEcCtD
Desvenlafaxine—Shock—Methylprednisolone—ankylosing spondylitis	0.00109	0.00357	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00108	0.00355	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00108	0.00355	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00108	0.00355	CcSEcCtD
Desvenlafaxine—Epistaxis—Methotrexate—ankylosing spondylitis	0.00108	0.00355	CcSEcCtD
Desvenlafaxine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00108	0.00355	CcSEcCtD
Desvenlafaxine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00108	0.00354	CcSEcCtD
Desvenlafaxine—Mental disorder—Prednisone—ankylosing spondylitis	0.00108	0.00354	CcSEcCtD
Desvenlafaxine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00108	0.00354	CcSEcCtD
Desvenlafaxine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00107	0.00352	CcSEcCtD
Desvenlafaxine—Malnutrition—Prednisone—ankylosing spondylitis	0.00107	0.00352	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00107	0.00351	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00107	0.0035	CcSEcCtD
Desvenlafaxine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00107	0.0035	CcSEcCtD
Desvenlafaxine—Convulsion—Betamethasone—ankylosing spondylitis	0.00107	0.0035	CcSEcCtD
Desvenlafaxine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00106	0.00349	CcSEcCtD
Desvenlafaxine—Hypertension—Betamethasone—ankylosing spondylitis	0.00106	0.00349	CcSEcCtD
Desvenlafaxine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00104	0.00343	CcSEcCtD
Desvenlafaxine—Anxiety—Betamethasone—ankylosing spondylitis	0.00104	0.00343	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00102	0.00333	CcSEcCtD
Desvenlafaxine—Vision blurred—Prednisone—ankylosing spondylitis	0.00101	0.00331	CcSEcCtD
Desvenlafaxine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00101	0.00331	CcSEcCtD
Desvenlafaxine—Insomnia—Triamcinolone—ankylosing spondylitis	0.001	0.00328	CcSEcCtD
Desvenlafaxine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000999	0.00328	CcSEcCtD
Desvenlafaxine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000994	0.00326	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000992	0.00325	CcSEcCtD
Desvenlafaxine—Shock—Betamethasone—ankylosing spondylitis	0.000988	0.00324	CcSEcCtD
Desvenlafaxine—Shock—Dexamethasone—ankylosing spondylitis	0.000988	0.00324	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000985	0.00323	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000985	0.00323	CcSEcCtD
Desvenlafaxine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00098	0.00322	CcSEcCtD
Desvenlafaxine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00098	0.00322	CcSEcCtD
Desvenlafaxine—Angioedema—Prednisone—ankylosing spondylitis	0.000979	0.00321	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000973	0.00319	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000971	0.00319	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000971	0.00319	CcSEcCtD
Desvenlafaxine—Vertigo—Prednisone—ankylosing spondylitis	0.000963	0.00316	CcSEcCtD
Desvenlafaxine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000962	0.00315	CcSEcCtD
Desvenlafaxine—Syncope—Prednisone—ankylosing spondylitis	0.000961	0.00315	CcSEcCtD
Desvenlafaxine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000959	0.00315	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000955	0.00313	CcSEcCtD
Desvenlafaxine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000955	0.00313	CcSEcCtD
Desvenlafaxine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000952	0.00312	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000942	0.00309	CcSEcCtD
Desvenlafaxine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000934	0.00306	CcSEcCtD
Desvenlafaxine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00093	0.00305	CcSEcCtD
Desvenlafaxine—Convulsion—Prednisone—ankylosing spondylitis	0.000929	0.00305	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000927	0.00304	CcSEcCtD
Desvenlafaxine—Hypertension—Prednisone—ankylosing spondylitis	0.000925	0.00304	CcSEcCtD
Desvenlafaxine—Chills—Methotrexate—ankylosing spondylitis	0.000923	0.00303	CcSEcCtD
Desvenlafaxine—Anxiety—Prednisone—ankylosing spondylitis	0.000909	0.00298	CcSEcCtD
Desvenlafaxine—Alopecia—Methotrexate—ankylosing spondylitis	0.000909	0.00298	CcSEcCtD
Desvenlafaxine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000909	0.00298	CcSEcCtD
Desvenlafaxine—Insomnia—Betamethasone—ankylosing spondylitis	0.000909	0.00298	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000906	0.00297	CcSEcCtD
Desvenlafaxine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000902	0.00296	CcSEcCtD
Desvenlafaxine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000902	0.00296	CcSEcCtD
Desvenlafaxine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000902	0.00296	CcSEcCtD
Desvenlafaxine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000896	0.00294	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000887	0.00291	CcSEcCtD
Desvenlafaxine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000877	0.00288	CcSEcCtD
Desvenlafaxine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000873	0.00286	CcSEcCtD
Desvenlafaxine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000873	0.00286	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000867	0.00285	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000867	0.00285	CcSEcCtD
Desvenlafaxine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000866	0.00284	CcSEcCtD
Desvenlafaxine—Fatigue—Betamethasone—ankylosing spondylitis	0.000866	0.00284	CcSEcCtD
Desvenlafaxine—Shock—Prednisone—ankylosing spondylitis	0.000861	0.00282	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000858	0.00281	CcSEcCtD
Desvenlafaxine—Tachycardia—Prednisone—ankylosing spondylitis	0.000854	0.0028	CcSEcCtD
Desvenlafaxine—Skin disorder—Prednisone—ankylosing spondylitis	0.00085	0.00279	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000846	0.00277	CcSEcCtD
Desvenlafaxine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000844	0.00277	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000816	0.00268	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000814	0.00267	CcSEcCtD
Desvenlafaxine—Vertigo—Methotrexate—ankylosing spondylitis	0.000805	0.00264	CcSEcCtD
Desvenlafaxine—Dizziness—Prednisolone—ankylosing spondylitis	0.000796	0.00261	CcSEcCtD
Desvenlafaxine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000794	0.00261	CcSEcCtD
Desvenlafaxine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000793	0.0026	CcSEcCtD
Desvenlafaxine—Insomnia—Prednisone—ankylosing spondylitis	0.000791	0.0026	CcSEcCtD
Desvenlafaxine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000786	0.00258	CcSEcCtD
Desvenlafaxine—Convulsion—Methotrexate—ankylosing spondylitis	0.000776	0.00255	CcSEcCtD
Desvenlafaxine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00076	0.00249	CcSEcCtD
Desvenlafaxine—Rash—Prednisolone—ankylosing spondylitis	0.000759	0.00249	CcSEcCtD
Desvenlafaxine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000758	0.00249	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000757	0.00248	CcSEcCtD
Desvenlafaxine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000756	0.00248	CcSEcCtD
Desvenlafaxine—Fatigue—Prednisone—ankylosing spondylitis	0.000754	0.00247	CcSEcCtD
Desvenlafaxine—Headache—Prednisolone—ankylosing spondylitis	0.000754	0.00247	CcSEcCtD
Desvenlafaxine—Constipation—Prednisone—ankylosing spondylitis	0.000748	0.00245	CcSEcCtD
Desvenlafaxine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000732	0.0024	CcSEcCtD
Desvenlafaxine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00073	0.0024	CcSEcCtD
Desvenlafaxine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000721	0.00236	CcSEcCtD
Desvenlafaxine—Asthenia—Betamethasone—ankylosing spondylitis	0.000721	0.00236	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000717	0.00235	CcSEcCtD
Desvenlafaxine—Nausea—Prednisolone—ankylosing spondylitis	0.000715	0.00235	CcSEcCtD
Desvenlafaxine—Skin disorder—Methotrexate—ankylosing spondylitis	0.00071	0.00233	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000707	0.00232	CcSEcCtD
Desvenlafaxine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000704	0.00231	CcSEcCtD
Desvenlafaxine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000702	0.0023	CcSEcCtD
Desvenlafaxine—Rash—Triamcinolone—ankylosing spondylitis	0.000698	0.00229	CcSEcCtD
Desvenlafaxine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000697	0.00229	CcSEcCtD
Desvenlafaxine—Rash—Methylprednisolone—ankylosing spondylitis	0.000697	0.00228	CcSEcCtD
Desvenlafaxine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000696	0.00228	CcSEcCtD
Desvenlafaxine—Headache—Triamcinolone—ankylosing spondylitis	0.000694	0.00228	CcSEcCtD
Desvenlafaxine—Headache—Methylprednisolone—ankylosing spondylitis	0.000692	0.00227	CcSEcCtD
Desvenlafaxine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000687	0.00225	CcSEcCtD
Desvenlafaxine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000687	0.00225	CcSEcCtD
Desvenlafaxine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000664	0.00218	CcSEcCtD
Desvenlafaxine—Dizziness—Betamethasone—ankylosing spondylitis	0.000664	0.00218	CcSEcCtD
Desvenlafaxine—Insomnia—Methotrexate—ankylosing spondylitis	0.000661	0.00217	CcSEcCtD
Desvenlafaxine—Nausea—Triamcinolone—ankylosing spondylitis	0.000658	0.00216	CcSEcCtD
Desvenlafaxine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000657	0.00215	CcSEcCtD
Desvenlafaxine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000656	0.00215	CcSEcCtD
Desvenlafaxine—Somnolence—Methotrexate—ankylosing spondylitis	0.00065	0.00213	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000645	0.00211	CcSEcCtD
Desvenlafaxine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000639	0.0021	CcSEcCtD
Desvenlafaxine—Vomiting—Betamethasone—ankylosing spondylitis	0.000639	0.0021	CcSEcCtD
Desvenlafaxine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000636	0.00208	CcSEcCtD
Desvenlafaxine—Rash—Dexamethasone—ankylosing spondylitis	0.000633	0.00208	CcSEcCtD
Desvenlafaxine—Rash—Betamethasone—ankylosing spondylitis	0.000633	0.00208	CcSEcCtD
Desvenlafaxine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000633	0.00208	CcSEcCtD
Desvenlafaxine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000633	0.00208	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000631	0.00207	CcSEcCtD
Desvenlafaxine—Fatigue—Methotrexate—ankylosing spondylitis	0.00063	0.00207	CcSEcCtD
Desvenlafaxine—Headache—Dexamethasone—ankylosing spondylitis	0.000629	0.00206	CcSEcCtD
Desvenlafaxine—Headache—Betamethasone—ankylosing spondylitis	0.000629	0.00206	CcSEcCtD
Desvenlafaxine—Asthenia—Prednisone—ankylosing spondylitis	0.000628	0.00206	CcSEcCtD
Desvenlafaxine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000599	0.00196	CcSEcCtD
Desvenlafaxine—Nausea—Betamethasone—ankylosing spondylitis	0.000597	0.00196	CcSEcCtD
Desvenlafaxine—Nausea—Dexamethasone—ankylosing spondylitis	0.000597	0.00196	CcSEcCtD
Desvenlafaxine—Dizziness—Prednisone—ankylosing spondylitis	0.000579	0.0019	CcSEcCtD
Desvenlafaxine—Vomiting—Prednisone—ankylosing spondylitis	0.000556	0.00182	CcSEcCtD
Desvenlafaxine—Rash—Prednisone—ankylosing spondylitis	0.000552	0.00181	CcSEcCtD
Desvenlafaxine—Dermatitis—Prednisone—ankylosing spondylitis	0.000551	0.00181	CcSEcCtD
Desvenlafaxine—Headache—Prednisone—ankylosing spondylitis	0.000548	0.0018	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000539	0.00177	CcSEcCtD
Desvenlafaxine—Asthenia—Methotrexate—ankylosing spondylitis	0.000525	0.00172	CcSEcCtD
Desvenlafaxine—Nausea—Prednisone—ankylosing spondylitis	0.00052	0.0017	CcSEcCtD
Desvenlafaxine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.0005	0.00164	CcSEcCtD
Desvenlafaxine—Dizziness—Methotrexate—ankylosing spondylitis	0.000483	0.00159	CcSEcCtD
Desvenlafaxine—Vomiting—Methotrexate—ankylosing spondylitis	0.000465	0.00152	CcSEcCtD
Desvenlafaxine—Rash—Methotrexate—ankylosing spondylitis	0.000461	0.00151	CcSEcCtD
Desvenlafaxine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000461	0.00151	CcSEcCtD
Desvenlafaxine—Headache—Methotrexate—ankylosing spondylitis	0.000458	0.0015	CcSEcCtD
Desvenlafaxine—Nausea—Methotrexate—ankylosing spondylitis	0.000434	0.00142	CcSEcCtD
